SI-BONE Statistics
Total Valuation
SI-BONE has a market cap or net worth of $665.13 million. The enterprise value is $556.20 million.
Important Dates
The last earnings date was Monday, February 23, 2026, after market close.
| Earnings Date | Feb 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SI-BONE has 44.17 million shares outstanding. The number of shares has increased by 3.60% in one year.
| Current Share Class | 44.17M |
| Shares Outstanding | 44.17M |
| Shares Change (YoY) | +3.60% |
| Shares Change (QoQ) | +0.74% |
| Owned by Insiders (%) | 3.28% |
| Owned by Institutions (%) | 96.11% |
| Float | 42.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.32 |
| Forward PS | 2.87 |
| PB Ratio | 3.77 |
| P/TBV Ratio | 3.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.55, with a Debt / Equity ratio of 0.21.
| Current Ratio | 8.55 |
| Quick Ratio | 7.05 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.50 |
Financial Efficiency
Return on equity (ROE) is -10.97% and return on invested capital (ROIC) is -6.67%.
| Return on Equity (ROE) | -10.97% |
| Return on Assets (ROA) | -5.95% |
| Return on Invested Capital (ROIC) | -6.67% |
| Return on Capital Employed (ROCE) | -10.47% |
| Weighted Average Cost of Capital (WACC) | 7.94% |
| Revenue Per Employee | $575,716 |
| Profits Per Employee | -$54,166 |
| Employee Count | 349 |
| Asset Turnover | 0.86 |
| Inventory Turnover | 1.35 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.72% in the last 52 weeks. The beta is 0.69, so SI-BONE's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | -13.72% |
| 50-Day Moving Average | 17.34 |
| 200-Day Moving Average | 17.07 |
| Relative Strength Index (RSI) | 38.69 |
| Average Volume (20 Days) | 551,349 |
Short Selling Information
The latest short interest is 2.69 million, so 6.09% of the outstanding shares have been sold short.
| Short Interest | 2.69M |
| Short Previous Month | 2.43M |
| Short % of Shares Out | 6.09% |
| Short % of Float | 6.30% |
| Short Ratio (days to cover) | 5.63 |
Income Statement
In the last 12 months, SI-BONE had revenue of $200.93 million and -$18.90 million in losses. Loss per share was -$0.44.
| Revenue | 200.93M |
| Gross Profit | 159.88M |
| Operating Income | -22.33M |
| Pretax Income | -18.90M |
| Net Income | -18.90M |
| EBITDA | -16.56M |
| EBIT | -22.33M |
| Loss Per Share | -$0.44 |
Full Income StatementBalance Sheet
The company has $147.82 million in cash and $36.69 million in debt, with a net cash position of $111.14 million or $2.52 per share.
| Cash & Cash Equivalents | 147.82M |
| Total Debt | 36.69M |
| Net Cash | 111.14M |
| Net Cash Per Share | $2.52 |
| Equity (Book Value) | 177.53M |
| Book Value Per Share | 4.07 |
| Working Capital | 190.84M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$675,000 and capital expenditures -$8.41 million, giving a free cash flow of -$9.09 million.
| Operating Cash Flow | -675,000 |
| Capital Expenditures | -8.41M |
| Free Cash Flow | -9.09M |
| FCF Per Share | -$0.21 |
Full Cash Flow StatementMargins
Gross margin is 79.57%, with operating and profit margins of -11.11% and -9.41%.
| Gross Margin | 79.57% |
| Operating Margin | -11.11% |
| Pretax Margin | -9.41% |
| Profit Margin | -9.41% |
| EBITDA Margin | -8.24% |
| EBIT Margin | -11.11% |
| FCF Margin | n/a |
Dividends & Yields
SI-BONE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.60% |
| Shareholder Yield | -3.60% |
| Earnings Yield | -2.83% |
| FCF Yield | -1.36% |
Analyst Forecast
The average price target for SI-BONE is $25.00, which is 66.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.00 |
| Price Target Difference | 66.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 15.22% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SI-BONE has an Altman Z-Score of 5.83 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.83 |
| Piotroski F-Score | 4 |
